Alendronic acid
Also known as: Alendronate sodium
Active ingredient description
Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Alendronic acid is the active ingredient of these drugs:
Spain
South Africa
Hong Kong
Brazil
Hong Kong
Poland
New Zealand
Hong Kong
Poland
Italy
Italy
Hong Kong South Africa
Italy
Hong Kong
Cyprus Finland Germany Ireland Singapore
Brazil
Brazil
France Ireland Netherlands
Brazil
South Africa
Tunisia
Australia South Africa
Italy
Brazil
South Africa
Australia
South Africa
Tunisia
Austria Brazil Canada France Germany
South Africa
Ireland
Italy
South Africa
Italy
Brazil
Cyprus
Singapore
Italy
Brazil
Hong Kong
South Africa
Italy
Italy
Austria
Brazil
Lithuania Poland
Brazil
Poland
Brazil
Brazil
Hong Kong
Ireland
Austria
Poland
Brazil
Italy
Italy
Hong Kong
Ireland
Poland
Spain
Spain
France
Germany Hong Kong Ireland
Alendronic acid is also found within below combination drugs:
ADROVANCE , ALENCALCI D3 , BENTEXO , BONENDRO , FONATPLUS , FOSALEN D3 , FOSAMAX D , FOSAMAX PLUS , FOSASTAD , FOSAVANCE , TEBONEVA , TRIDEPOS , VANTAVO
Product monographs
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):
Structural formula
3D molecular structure
Unique ingredient identifier (UNII)
X1J18R4W8P - ALENDRONIC ACID
CAS registry number
121268-17-5 - Alendronate sodium trihydrate
66376-36-1 - alendronic acid
SNOMED-CT
391730008 - Alendronic acid (substance)